COMPOSITIONS ET PROCEDES POUR LE TRAITEMENT DE LA MICROANGIOPATHIE THROMBOTIQUE ASSOCIEE A LA TRANSPLANTATION DE CELLULES SOUCHES HEMATOPOIETIQUES (TCSH)
Disclosed are drugs capable of inhibiting the complement pathway for use for treating hematopoietic stem cell transplant (HSCT) associated thrombotic microangiopathy (HSCT-TMA, also called TA-TMA) in a subject that has undergone an HSCT. Also disclosed are methods of using drugs capable of inhibiting the complement pathway for use for treating hematopoietic stem cell transplant (HSCT) associated thrombotic microangiopathy (HSCT-TMA) in a subject that has undergone an HSCT.